GE HealthCare Technologies Inc. reported an insider ownership change involving Kevin Lobo in a Form 4 filed on May 26, 2026. The reported transaction date was May 22, 2026, and the security involved was GE HealthCare common stock, par value $0.01 per share. The filing indicates a transaction involving 10,000 shares at a price of $64.18 per share, implying an aggregate transaction value of approximately $641,800. The excerpt provided does not specify the Form 4 transaction code, so it is not possible from the document text to determine whether the transaction was an open-market purchase, sale, equity award, or another type of reportable ownership change. It also does not disclose the number of shares beneficially owned by Lobo after the transaction or whether the holdings were direct or indirect. No option exercise, vesting schedule, derivative security, or footnote explanation is included in the provided filing text. The form was signed on Lobo’s behalf by Frank R. Jimenez, GE HealthCare’s General Counsel and Corporate Secretary, acting as attorney-in-fact, on May 26, 2026. The filing matters because Form 4 reports are used to disclose changes in beneficial ownership by company insiders, directors, officers, or other reporting persons. In this case, the key disclosed fact is that Kevin Lobo reported a 10,000-share GEHC common stock transaction on May 22, 2026, at $64.18 per share, but the limited filing text does not provide enough detail to interpret the transaction’s direction or its effect on his remaining ownership.